Quanterix Corporation (NASDAQ:QTRX) Given Average Recommendation of “Hold” by Analysts

Quanterix Corporation (NASDAQ:QTRX) has received a consensus recommendation of “Hold” from the five analysts that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $11.3333.

Several equities research analysts recently commented on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Quanterix in a research note on Wednesday, October 8th. Canaccord Genuity Group boosted their price target on Quanterix from $5.00 to $8.00 and gave the stock a “hold” rating in a research report on Monday, December 22nd. Finally, Wall Street Zen raised Quanterix from a “sell” rating to a “hold” rating in a research report on Monday, December 29th.

Institutional Trading of Quanterix

Several institutional investors have recently bought and sold shares of QTRX. Quarry LP increased its stake in Quanterix by 277,300.0% during the 3rd quarter. Quarry LP now owns 5,548 shares of the company’s stock valued at $30,000 after purchasing an additional 5,546 shares in the last quarter. State of Wyoming bought a new stake in shares of Quanterix during the first quarter valued at approximately $47,000. R Squared Ltd purchased a new position in Quanterix in the 3rd quarter worth approximately $64,000. HUB Investment Partners LLC bought a new position in Quanterix in the 2nd quarter valued at approximately $81,000. Finally, Brevan Howard Capital Management LP purchased a new stake in Quanterix during the 2nd quarter valued at $96,000. 86.48% of the stock is owned by hedge funds and other institutional investors.

Quanterix Stock Up 23.8%

NASDAQ QTRX opened at $8.06 on Tuesday. The firm has a market capitalization of $376.48 million, a PE ratio of -3.46 and a beta of 1.00. The stock’s 50 day moving average is $6.54 and its 200 day moving average is $5.85. Quanterix has a twelve month low of $4.05 and a twelve month high of $10.90.

Quanterix (NASDAQ:QTRX) last announced its quarterly earnings data on Monday, November 10th. The company reported ($0.36) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.13). The firm had revenue of $40.23 million for the quarter, compared to analysts’ expectations of $37.85 million. Quanterix had a negative net margin of 73.47% and a negative return on equity of 21.34%. On average, research analysts anticipate that Quanterix will post -0.98 earnings per share for the current year.

About Quanterix

Quanterix Corporation is a life sciences and diagnostics company specializing in ultra-sensitive digital immunoassay platforms. Its proprietary Single Molecule Array (Simoa) technology enables researchers to detect and quantify proteins, peptides and nucleic acids at femtomolar concentrations, offering sensitivity that surpasses traditional immunoassay methods. By translating single-molecule detection into routine laboratory workflows, Quanterix aims to accelerate biomarker discovery and the development of novel diagnostics and therapeutics.

The company’s core product portfolio includes the Simoa HD-1 and HD-X Analyzers, which automate high-throughput digital immunoassays for quantifying low-abundance biomarkers.